Patent Cooperation Treaty

ICR 201601-0651-010

OMB: 0651-0021

Federal Form Document

IC Document Collections
IC ID
Document
Title
Status
4689 Unchanged
219809
New
219808
New
219807
New
219806
New
219805
New
219804
New
219803
New
219802
New
219801
New
219800
New
219799
New
219798
New
219797
New
219796
New
219795
New
219794
New
219793
New
219792
New
219791
New
219790
New
219789
New
191415
Unchanged
191414
Unchanged
191413
Unchanged
191412
Unchanged
191411 Unchanged
191410 Unchanged
191409
Unchanged
191408 Unchanged
191407
Unchanged
191406
Unchanged
191405
Unchanged
191404 Unchanged
191403
Unchanged
191402
Unchanged
191401 Unchanged
191398
Unchanged
191397
Unchanged
191396 Unchanged
191395 Unchanged
191394
Unchanged
191393
Unchanged
ICR Details
0651-0021 201601-0651-010
Historical Active 201304-0651-002
DOC/PTO
Patent Cooperation Treaty
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 03/21/2016
Retrieve Notice of Action (NOA) 01/29/2016
  Inventory as of this Action Requested Previously Approved
06/30/2016 06/30/2016 06/30/2016
923,310 0 353,669
371,626 0 348,686
291,867,138 0 120,671,373

The purpose of the Patent Cooperation Treaty (PCT) is to provide a standardized filing format and procedure that allows an applicant to seek protection for an invention in several countries by filing one international application in one location, in one language, and paying one initial set of fees. The information in this collection is used by the public to submit a patent application under the PCT and by the USPTO to fulfill its obligation to process, search, and examine the application as directed by the treaty.

US Code: 35 USC 351-376 Name of Law: null
  
None

Not associated with rulemaking

  78 FR 7759 02/04/2013
78 FR 24184 04/24/2013
No

43
IC Title Form No. Form Name
English translation after thirty months from priority date
Supplemental search fee when required, per additional invention
[PCT National Stage] Claims – multiple dependent
Acceptance of an unintentionally delayed claim for priority, or for filing a request for the restoration of the right of priority
National Stage Examination Fee – U.S. was the ISA or IPEA and all claims satisfy PCT Article 33(1)-(4)
Transmitting application to Intl. Bureau to act as receiving office
National Stage Examination Fee – all other situations
Search fee, examination fee or oath or declaration after thirty months from priority date
[PCT National Stage] Claims – extra total (over 20)
Transmittal fee
Search fee – regardless of whether there is a corresponding application (see 35 U.S.C. 361(d) and PCT Rule 16)
Preliminary examination fee – U.S. was not the ISA
[PCT National Stage] Claims – extra independent (over three)
PCT/Model of General Power of Attorney
Acceptance of an unintentionally delayed claim for priority (37 CFR 1.78(a)(3))
Petition for Revival of an International Application for Patent Designating the U.S. Abandoned Unintentionally Under 37 CFR 1.137(b) PTO/SB/64/PCT Petition for Revival of an International Application for Patent Designating the U.S. Abandoned Unintentionally Under 37 CFR 1.137(b)
Transmittal Letter to the United States Designated/Elected Office (DO/EO/US) Concerning a Submission Under 35 U.S.C. 371 PTO-1390 Transmittal Letter to the United States Designated/Elected Office (DO/EO/US) Concerning a Filing Under 35 U.S.C. 371
PCT/Model of Power of Attorney
Request and Fee Calculation Sheet PCT/RO/101 Request and Fee Calculation Sheet (Annex and Notes)
Fee Authorization
Requests to transmit copies of international application
Translations
Petitions to the Commissioner for international applications
Petition for Revival of an International Application for Patent Designating the U.S. Abandoned Unavoidably Under 37 CFR 1.137(a) PTO/SB/61/PCT Petition for Revival of an International Application for Patent Designating the U.S. Abandoned Unavoidably Under 37 CFR 1.137(a)
Transmittal Letter to the United States Receiving Office (RO/US) PTO-1382 Transmittal Letter to the United States Receiving Office
Withdrawal of international application PCT/IB/372 Notice of Withdrawal
Application Data Sheet (35 U.S.C. 371 applications)
National Stage Search Fee – U.S. was the ISA
National Stage Search Fee - search report prepared and provided to USPTO
National Stage Search Fee – all other situations
National Stage Search Fee - U.S. was the ISA or IPEA and al claims satisfy PCT Article 33(1)-(4)
Preliminary examination fee – U.S. was the ISA
Supplemental examination fee per additional invention
Basic National Stage Fee
National Stage Application Size Fee – for each additional 50 sheets that exceed 100 sheets
Request for the restoration of the right of priority
Petitions to the Commissioner in national stage examination
Response to invitation to correct defects
Request for rectification of obvious errors
Description/claims/drawings/abstracts
Indications Relating to a Deposited Microorganism PCT/RO/134 Indications Relating to Deposited Microorganism or Other Biological Material
Demand and Fee Calculation Sheet PCT/IPEA/401 Demand and Fee Calculation Sheet
Amendments (Article 34)

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 923,310 353,669 0 569,641 0 0
Annual Time Burden (Hours) 371,626 348,686 0 22,940 0 0
Annual Cost Burden (Dollars) 291,867,138 120,671,373 0 171,195,765 0 0
Yes
Miscellaneous Actions
No
Filing fees have been added to collection 0651-0021 from collection 0651-0072, following the discontinuation of 0651-0072. This program change results in an increase of responses, time burden, and cost burden.

$7,005,300
No
No
No
No
No
Uncollected
Raul Tamayo 5712727728 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/29/2016


© 2024 OMB.report | Privacy Policy